Effects of mizagliflozin, a selective SGLT1 inhibitor, on chronic hypoperfusion-induced vascular cognitive impairment.Nanae Ishida,Maki Saito,Sachiko Sato,Yu Tezuka,Atsushi Sanbe,Eiichi Taira,Masamichi HiroseProceedings for Annual Meeting of The Japanese Pharmacological Society（2022）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
